High-cell-density culture systems
Bioreactor hardware engineered to sustain far higher viable-cell densities than a conventional stirred tank — Repligen's XCell ATF perfusion system (100M+ cells/mL), PBS Biotech's Vertical-Wheel bioreactors, Univercells Technologies' scale-X fixed-bed platform, and Cellexus's CellMaker airlift bioreactors — the equipment layer that lets a fed-batch or perfusion process pack more cells and more product into the same reactor volume.
1 · What it gives
A high-cell-density culture system is bioreactor hardware purpose-built to sustain viable-cell concentrations well above what a conventional stirred tank can support, typically by continuously removing spent media and retaining or replenishing cells rather than relying on a single batch of nutrients. The category spans four distinct mechanical approaches: an external cell-retention perfusion loop (alternating tangential flow, or ATF) that lets a stirred bioreactor run continuously at high density; a low-shear vertical impeller design that suspends cell aggregates gently enough to reach high densities without damaging fragile cell types; a fixed-bed design where cells grow attached to a matrix through which media flows continuously; and an airlift design that mixes and aerates culture using gas bubbles instead of a mechanical impeller. Repligen’s XCell ATF system is documented to sustain viable cell densities over 100 million cells/mL — roughly 10x what a standard fed-batch stirred tank reaches — by combining continuous perfusion with reduced energy use and longer run times.
The key directions of high-cell-density culture systems are:
- Alternating tangential flow (ATF) perfusion (Repligen): an external hollow-fiber filter module alternates flow direction to retain cells inside the bioreactor while continuously removing spent media, enabling continuous bioprocessing at densities over 100 million cells/mL with reduced energy use versus batch methods.
- Vertical-Wheel low-shear mixing (PBS Biotech): a vertical impeller design suspends cell aggregates (including sensitive iPSC/stem-cell aggregates) with gentle, uniform mixing, scaling from research-scale systems to cell-therapy manufacturing volumes.
- Fixed-bed perfusion (Univercells Technologies): cells attach to a fixed matrix bed through which culture media flows continuously, with the scale-X platform scaling from a compact 0.5 m² research system to a 600 m² commercial-manufacturing configuration with minimal process adaptation.
- Airlift bioreactors (Cellexus): the CellMaker range uses patented airlift technology — aeration and mixing via gas bubbles rather than a mechanical impeller — with a low-flow controller option specifically for shear-sensitive cell types.
Sectoral value chain#
[Bioreactor hardware design] ──> [Cell-retention/perfusion subsystem] ──> [Single-use consumable manufacturing] ──> [Process integration & validation]
│
(scale-up/scale-down engineering)
│
▼
[Consumable reorder / service contract] <─── [Commercial manufacturing deployment] <────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Bioreactor hardware design | Engineering the core vessel and mixing/aeration mechanism (ATF loop, vertical wheel, fixed bed, airlift) to sustain high cell density | In: mechanical/fluid-dynamics engineering, cell-culture performance data. Out: a validated high-density bioreactor design. |
| Cell-retention/perfusion subsystem | Building the filter, matrix or flow mechanism that keeps cells in the reactor while removing spent media or waste | In: filtration/matrix hardware, flow-control components. Out: a working cell-retention or perfusion loop. |
| Single-use consumable manufacturing | Manufacturing the single-use bags, filter cartridges or fixed-bed cartridges that contact the culture in each production run | In: biocompatible plastics, filter media, matrix material. Out: sterile, single-use bioprocess consumables. |
| Process integration & validation | Integrating the bioreactor into a full upstream process and validating performance (cell density, viability, product titer) against cGMP requirements | In: bioreactor system, cell line, process development data. Out: a validated, scalable upstream process. |
| Commercial manufacturing deployment | Deploying the system at clinical or commercial manufacturing scale for biologics, vaccines, cell therapy or viral-vector production | In: validated process, GMP facility. Out: manufactured biologic drug substance or cell-therapy product. |
| Ongoing operation & consumable resupply | The end use: running production batches or continuous campaigns, consuming single-use hardware and requiring periodic resupply | In: system + consumables + operating campaign. Out: ongoing biologic or cell-therapy product output. |
Cross-cutting technologies of the sector:
- Alternating tangential flow (ATF) perfusion: a hollow-fiber filter module alternates flow direction to retain cells while continuously exchanging spent media for fresh, sustaining very high viable-cell densities in a stirred-tank format.
- Vertical-wheel low-shear mixing: a vertical impeller design generates gentle, uniform mixing suited to shear-sensitive cell aggregates such as iPSCs and stem-cell-derived therapies.
- Fixed-bed perfusion: cells grow attached to a fixed matrix bed through which media flows continuously, decoupling cell density from the mixing-shear constraints of a suspension culture.
2 · What it replaces 3 · matched by industry
3 · How to implement 6 steps
- 1Bioreactor hardware designFermentation & cultivationEquipment & engineeringThe core vessel and mixing/aeration mechanism (ATF loop, vertical wheel, fixed bed, or airlift) is engineered to sustain high cell density without excessive shear or oxygen limitation.Who can do this step matched automaticallyPBS Biotech United States✓ ISO 9001 industrial scale“PBS Biotech is advancing the future of cell therapy manufacturing through innovative, single-use bioreactor solutions designed specifically for shear-sensitive cell cultures.”Loopworm India6,000 tonnes/year industrial scale“At Loopworm, we are building the future of sustainable biomanufacturing.”Cell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”BIONET Spain200 litres industrial scale“• A range of bioreactors and TFF systems for different cell types, including glass and stainless steel stirred bioreactors, glass airlift bioreactors and single-use rocking systems …”Pensées South Koreapilot scale“We have developed a high-efficiency bioreactor specifically for cultured meat production and have secured safety and cost-effectiveness by developing a medium using food-grade …”
- 2Cell-retention/perfusion subsystemThe filter, matrix or flow mechanism that keeps cells in the reactor while continuously exchanging spent media for fresh is built and integrated with the core vessel.
- 3Single-use consumable manufacturingContract manufacturing (CMO/CDMO)The single-use bags, filter cartridges or fixed-bed matrix cartridges that contact the culture in each production run are manufactured to sterile, biocompatible specifications.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Cell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”PBS Biotech United States✓ ISO 9001 industrial scale“Trusted by leading biotech companies, academic institutions, and contract manufacturers worldwide, PBS Biotech is committed to simplifying cell therapy manufacturing while …”Stellapps India240,000 liters/day“Stellapps is an end-to-end dairy technology company digitizing and optimizing milk production, procurement, and cold-chain management via its SmartMoo™ IoT/cloud platform, which …”
- 4Process integration & validationTesting & analyticsThe bioreactor is integrated into a full upstream process and validated against cGMP requirements for cell density, viability and product titer.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Turion Labs Singapore“Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
- 5Commercial manufacturing deploymentContract manufacturing (CMO/CDMO)The validated system is deployed at clinical or commercial manufacturing scale for biologics, vaccines, cell therapy or viral-vector production.Who can do this step matched automaticallyEsco Aster Singapore✓ ISO 9001 5,000 L industrial scale“Esco Aster (Singapore) is a cGMP contract research, development and manufacturing organization (CRDMO/CDMO) and bioinnovation venture accelerator that helps clients and …”Cell AgriTech Malaysia5,000 L industrial scale“At Cell AgriTech, we position ourselves as Asia’s first dedicated CDMO for cultivated meat and plant cell culture.”PBS Biotech United States✓ ISO 9001 industrial scale“Trusted by leading biotech companies, academic institutions, and contract manufacturers worldwide, PBS Biotech is committed to simplifying cell therapy manufacturing while …”Stellapps India240,000 liters/day“Stellapps is an end-to-end dairy technology company digitizing and optimizing milk production, procurement, and cold-chain management via its SmartMoo™ IoT/cloud platform, which …”
- 6Ongoing operation & consumable resupplyEquipment & engineeringProduction batches or continuous perfusion campaigns run on an ongoing basis, consuming single-use hardware that requires periodic resupply from the equipment vendor.Who can do this step matched automaticallyCell AgriTech Malaysia5,000 L industrial scale“We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”Papop Thailand✓ ISO 9001 15,770 MT industrial scale“Papop Company Limited is a privately held Thailand-based green tech provider specializing in wastewater treatment and biogas technology (including UASB/anaerobic digestion and H2S …”N.Thing South Koreaindustrial scale“Services: turnkey delivery including design, construction, and operations consulting; in-house cultivation and supply to grocery, food service, catering, and manufacturing.”163,050 tonnes“[China Everbright Environment Group Limited — China Everbright Environment Group is a leading integrated environmental protection conglomerate with diversified core businesses in …”
4 · Who delivers
Matched suppliers (matched automatically)
| PBS Biotech | United States | Equipment | active |
| BIONET | Spain | Equipment | active |
| Integriculture | Japan | Equipment | active |
| Caladan Bio | United States | Producer | active |
| Pensées | South Korea | Producer | active |
| Wildtype | United States | Producer | active |
| Cell AgriTech | Malaysia | Research / RTO | active |
| Simple Planet | South Korea | Producer | active |
| Unibio | Denmark | Producer | active |
| AGC Biologics | United States | Producer | active |
| CellMEAT | South Korea | Producer | active |
In the services and supply catalogue 2 · paid service
Upstream — fermentation & cell culture · Single-use assemblies & bags
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Repligen | 🇺🇸 USA | XCell ATF System | Alternating tangential flow perfusion; sustains 100M+ cells/mL; NASDAQ: RGEN, founded 1981 | Commercial |
| PBS Biotech | 🇺🇸 USA | Vertical-Wheel bioreactors (incl. 15L cell-therapy scale-up system) | Low-shear vertical impeller mixing for sensitive cell aggregates | Commercial |
| Univercells Technologies | 🇧🇪 Belgium | scale-X nexo (0.5 m²) and nitro (600 m²) fixed-bed systems | Fixed-bed perfusion; scales research-to-commercial with minimal adaptation | Commercial |
| Cellexus | 🇬🇧 UK | CellMaker Plus, Regular and Low Flow airlift bioreactors | Patented airlift aeration/mixing; Low Flow variant for shear-sensitive cells | Commercial |
5 · Rules & route to market
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US anchors the two most widely adopted high-cell-density approaches: Repligen’s ATF perfusion technology and PBS Biotech’s Vertical-Wheel bioreactors both sell into biologics and cell-therapy manufacturing globally.
ATF perfusion systems, Vertical-Wheel low-shear bioreactors#
- Repligen (NASDAQ: RGEN, founded 1981): sells the XCell ATF System, which sustains viable cell densities over 100 million cells/mL through continuous alternating-tangential-flow perfusion, reducing energy use and enabling longer run times versus conventional batch or fed-batch upstream processes.
- PBS Biotech: sells single-use Vertical-Wheel bioreactors (including a 15L system for cell-therapy scale-up) using a low-shear vertical impeller design documented in peer-reviewed research to predict maximum achievable cell density before oxygen-transfer becomes limiting for iPSC aggregate cultures.
European Union
Belgium and the UK anchor the confirmed EU activity in this screen: Univercells Technologies’ fixed-bed platform and Cellexus’s airlift bioreactors both serve biologics and viral-vector manufacturing.
fixed-bed perfusion platforms, airlift bioreactors#
- Univercells Technologies (Belgium): sells the scale-X platform, a fixed-bed perfusion bioreactor line scaling from a 0.5 m² scale-X nexo research system to a 600 m² scale-X nitro commercial-manufacturing configuration for vaccine and viral-vector production, engineered to overcome the scale-up limitations of traditional stirred-tank culture.
- Cellexus (UK): sells the CellMaker range of single-use airlift bioreactors, using patented gas-bubble aeration and mixing instead of a mechanical impeller, with a Low Flow Controller variant delivering 0.06-0.25 VVM airflow specifically for shear-sensitive cell types.
China
No China-based vendor with a confirmed dedicated high-cell-density culture system product line surfaced in this screen. A targeted search for a domestic perfusion/high-density bioreactor maker returned no source confirming an active, currently-sold product, though China’s broader single-use bioprocessing equipment manufacturing base (serving both domestic and export biologics manufacturing) continues to expand.
bioprocessing equipment manufacturing base, no confirmed dedicated high-density system brand#
- Market structure: Chinese biologics manufacturers increasingly adopt perfusion and high-density culture processes, but this screen found no confirmed domestic equipment brand offering a dedicated ATF, Vertical-Wheel, fixed-bed or airlift high-cell-density system comparable to the international vendors in this article.
- Distribution gap: high-cell-density bioreactor hardware deployed in Chinese biologics manufacturing is, on the evidence in this screen, predominantly imported from the US and EU vendors confirmed here rather than sourced from a domestic dedicated-system brand.
6 · Money: tenders & grants
7 · Tech stack & innovations
The category’s shared engineering challenge is sustaining a much higher concentration of living cells per unit reactor volume than a conventional stirred tank, without starving cells of oxygen/nutrients or damaging them with excessive shear.
- Cell-retention perfusion engineering:
- ATF systems use a hollow-fiber filter module and alternating flow direction to retain cells inside the bioreactor while continuously exchanging spent media for fresh — avoiding the filter fouling that a one-directional (tangential) flow would cause over a long continuous run.
- Fixed-bed systems instead physically anchor cells to a matrix, so cell density is decoupled from the fluid-dynamics constraints that limit a stirred suspension culture.
- Low-shear mixing for sensitive cell types:
- Vertical-wheel and airlift designs both avoid the high localized shear a conventional Rushton-type impeller generates, a requirement for culturing shear-sensitive cell types like iPSC aggregates and certain cell-therapy products at high density without damaging them.
- Peer-reviewed research on Vertical-Wheel systems has characterized the oxygen-transfer rate ceiling that ultimately limits achievable cell density before oxygen becomes the constraining factor.
- Scale-up/scale-down consistency:
- Fixed-bed platforms like scale-X are engineered so a research-scale system (0.5 m²) and a commercial-manufacturing system (600 m²) share the same underlying bed technology, minimizing the process-characterization work needed when moving from development to commercial scale.
Sources 4 · 0 independent · 4 producer sites
Producers' own sites 4
- Repligen producer checked 2026-05-19 · link not kept
- Pbs biotech producer checked 2026-07-21 · link not kept
- Univercells technologies producer checked 2026-04-30 · link not kept
- Cellexus producer checked 2025-05-21 · link not kept